Titre : Amidohydrolases

Amidohydrolases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Auditory Pathways

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une déficience en amidohydrolases ?

Des tests enzymatiques et des analyses génétiques peuvent être effectués.
Déficience enzymatique Tests diagnostiques
#2

Quels tests sanguins sont utilisés pour évaluer les amidohydrolases ?

Les dosages enzymatiques dans le sérum peuvent indiquer l'activité des amidohydrolases.
Tests sanguins Amidohydrolases
#3

Les biopsies sont-elles nécessaires pour le diagnostic ?

Dans certains cas, des biopsies peuvent être nécessaires pour évaluer l'activité enzymatique.
Biopsie Diagnostic
#4

Quels symptômes peuvent indiquer un problème d'amidohydrolases ?

Des troubles digestifs ou métaboliques peuvent signaler une anomalie enzymatique.
Symptômes Troubles métaboliques
#5

Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?

L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications associées.
Imagerie médicale Complications

Symptômes 5

#1

Quels sont les symptômes d'une déficience en amidohydrolases ?

Les symptômes incluent des douleurs abdominales, des ballonnements et des troubles digestifs.
Déficience enzymatique Symptômes
#2

Les troubles métaboliques sont-ils liés aux amidohydrolases ?

Oui, une activité enzymatique anormale peut entraîner divers troubles métaboliques.
Troubles métaboliques Amidohydrolases
#3

Y a-t-il des signes cutanés associés aux troubles enzymatiques ?

Des éruptions cutanées peuvent survenir en raison de déséquilibres métaboliques.
Signes cutanés Troubles enzymatiques
#4

Les symptômes varient-ils selon le type d'amidohydrolase ?

Oui, les symptômes peuvent varier en fonction de l'enzyme spécifique impliquée.
Variabilité des symptômes Amidohydrolases
#5

Les symptômes sont-ils immédiats ou progressifs ?

Ils peuvent être progressifs, se développant avec le temps en fonction de la déficience.
Symptômes progressifs Déficience enzymatique

Prévention 5

#1

Peut-on prévenir les troubles liés aux amidohydrolases ?

La prévention est difficile, mais un mode de vie sain peut réduire les risques.
Prévention Mode de vie sain
#2

Les tests génétiques peuvent-ils aider à la prévention ?

Oui, les tests génétiques peuvent identifier les personnes à risque de déficiences enzymatiques.
Tests génétiques Prévention
#3

Une alimentation équilibrée peut-elle prévenir ces troubles ?

Une alimentation équilibrée peut soutenir la santé enzymatique, mais ne garantit pas la prévention.
Alimentation équilibrée Santé enzymatique
#4

Les vaccinations ont-elles un rôle dans la prévention ?

Les vaccinations ne sont pas directement liées à la prévention des troubles enzymatiques.
Vaccinations Prévention
#5

L'éducation sur les maladies héréditaires est-elle importante ?

Oui, l'éducation peut aider les familles à comprendre et à gérer les risques associés.
Éducation Maladies héréditaires

Traitements 5

#1

Quels traitements existent pour les déficiences en amidohydrolases ?

Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques.
Traitements Suppléments enzymatiques
#2

Les médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?

Certains médicaments peuvent moduler l'activité enzymatique, mais leur efficacité varie.
Médicaments Amidohydrolases
#3

La thérapie génique est-elle une option pour ces troubles ?

La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles.
Thérapie génique Troubles enzymatiques
#4

Les changements alimentaires peuvent-ils améliorer les symptômes ?

Oui, une alimentation adaptée peut aider à gérer les symptômes liés aux déficiences enzymatiques.
Changements alimentaires Gestion des symptômes
#5

Y a-t-il des traitements naturels pour les troubles d'amidohydrolases ?

Certaines approches naturelles peuvent aider, mais il est essentiel de consulter un médecin.
Traitements naturels Consultation médicale

Complications 5

#1

Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?

Des complications digestives, métaboliques et neurologiques peuvent se développer.
Complications Troubles digestifs
#2

Les troubles d'amidohydrolases peuvent-ils affecter la croissance ?

Oui, des déficiences enzymatiques peuvent entraîner des retards de croissance chez les enfants.
Retards de croissance Déficiences enzymatiques
#3

Y a-t-il des risques de maladies auto-immunes ?

Certaines études suggèrent un lien entre les troubles enzymatiques et les maladies auto-immunes.
Maladies auto-immunes Troubles enzymatiques
#4

Les complications sont-elles réversibles ?

Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes.
Complications réversibles Gestion des symptômes
#5

Comment surveiller les complications potentielles ?

Des suivis réguliers avec des professionnels de santé sont essentiels pour surveiller les complications.
Surveillance Professionnels de santé

Facteurs de risque 5

#1

Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?

Les facteurs incluent des antécédents familiaux, des maladies génétiques et des régimes alimentaires déséquilibrés.
Facteurs de risque Antécédents familiaux
#2

L'âge influence-t-il le risque de troubles enzymatiques ?

Oui, certains troubles enzymatiques se manifestent plus fréquemment à des âges spécifiques.
Âge Troubles enzymatiques
#3

Les maladies métaboliques augmentent-elles le risque ?

Oui, les maladies métaboliques peuvent prédisposer à des déficiences en amidohydrolases.
Maladies métaboliques Déficiences enzymatiques
#4

Le mode de vie peut-il influencer le risque ?

Un mode de vie malsain, incluant une mauvaise alimentation, peut augmenter le risque.
Mode de vie Risque
#5

Les facteurs environnementaux jouent-ils un rôle ?

Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes liés aux amidohydrolases.
Facteurs environnementaux Expression génétique
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Amidohydrolases : Questions médicales les plus fréquentes", "headline": "Amidohydrolases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Amidohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-19", "dateModified": "2025-03-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Amidohydrolases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hydrolases", "url": "https://questionsmedicales.fr/mesh/D006867", "about": { "@type": "MedicalCondition", "name": "Hydrolases", "code": { "@type": "MedicalCode", "code": "D006867", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "N-acetylmuramoyl-l-alanine amidase", "alternateName": "N-Acetylmuramoyl-L-alanine Amidase", "url": "https://questionsmedicales.fr/mesh/D009238", "about": { "@type": "MedicalCondition", "name": "N-acetylmuramoyl-l-alanine amidase", "code": { "@type": "MedicalCode", "code": "D009238", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.030" } } }, { "@type": "MedicalWebPage", "name": "Allophanate hydrolase", "alternateName": "Allophanate Hydrolase", "url": "https://questionsmedicales.fr/mesh/D000492", "about": { "@type": "MedicalCondition", "name": "Allophanate hydrolase", "code": { "@type": "MedicalCode", "code": "D000492", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.060" } } }, { "@type": "MedicalWebPage", "name": "Formamidase", "alternateName": "Arylformamidase", "url": "https://questionsmedicales.fr/mesh/D005558", "about": { "@type": "MedicalCondition", "name": "Formamidase", "code": { "@type": "MedicalCode", "code": "D005558", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.100" } } }, { "@type": "MedicalWebPage", "name": "Asparaginase", "alternateName": "Asparaginase", "url": "https://questionsmedicales.fr/mesh/D001215", "about": { "@type": "MedicalCondition", "name": "Asparaginase", "code": { "@type": "MedicalCode", "code": "D001215", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.116" } } }, { "@type": "MedicalWebPage", "name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase", "alternateName": "Aspartylglucosylaminase", "url": "https://questionsmedicales.fr/mesh/D001227", "about": { "@type": "MedicalCondition", "name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase", "code": { "@type": "MedicalCode", "code": "D001227", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.125" } } }, { "@type": "MedicalWebPage", "name": "bêta-Lactamases", "alternateName": "beta-Lactamases", "url": "https://questionsmedicales.fr/mesh/D001618", "about": { "@type": "MedicalCondition", "name": "bêta-Lactamases", "code": { "@type": "MedicalCode", "code": "D001618", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cephalosporinase", "alternateName": "Cephalosporinase", "url": "https://questionsmedicales.fr/mesh/D002510", "about": { "@type": "MedicalCondition", "name": "Cephalosporinase", "code": { "@type": "MedicalCode", "code": "D002510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180.229" } } }, { "@type": "MedicalWebPage", "name": "Penicillinase", "alternateName": "Penicillinase", "url": "https://questionsmedicales.fr/mesh/D010405", "about": { "@type": "MedicalCondition", "name": "Penicillinase", "code": { "@type": "MedicalCode", "code": "D010405", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180.697" } } } ] }, { "@type": "MedicalWebPage", "name": "Biotinidase", "alternateName": "Biotinidase", "url": "https://questionsmedicales.fr/mesh/D043523", "about": { "@type": "MedicalCondition", "name": "Biotinidase", "code": { "@type": "MedicalCode", "code": "D043523", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.200" } } }, { "@type": "MedicalWebPage", "name": "Ceramidases", "alternateName": "Ceramidases", "url": "https://questionsmedicales.fr/mesh/D055572", "about": { "@type": "MedicalCondition", "name": "Ceramidases", "code": { "@type": "MedicalCode", "code": "D055572", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Acid Ceramidase", "alternateName": "Acid Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055573", "about": { "@type": "MedicalCondition", "name": "Acid Ceramidase", "code": { "@type": "MedicalCode", "code": "D055573", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.100" } } }, { "@type": "MedicalWebPage", "name": "Alkaline Ceramidase", "alternateName": "Alkaline Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055574", "about": { "@type": "MedicalCondition", "name": "Alkaline Ceramidase", "code": { "@type": "MedicalCode", "code": "D055574", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.300" } } }, { "@type": "MedicalWebPage", "name": "Neutral Ceramidase", "alternateName": "Neutral Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055576", "about": { "@type": "MedicalCondition", "name": "Neutral Ceramidase", "code": { "@type": "MedicalCode", "code": "D055576", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.650" } } } ] }, { "@type": "MedicalWebPage", "name": "Dihydro-orotase", "alternateName": "Dihydroorotase", "url": "https://questionsmedicales.fr/mesh/D004080", "about": { "@type": "MedicalCondition", "name": "Dihydro-orotase", "code": { "@type": "MedicalCode", "code": "D004080", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.280" } } }, { "@type": "MedicalWebPage", "name": "Glutaminase", "alternateName": "Glutaminase", "url": "https://questionsmedicales.fr/mesh/D005972", "about": { "@type": "MedicalCondition", "name": "Glutaminase", "code": { "@type": "MedicalCode", "code": "D005972", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.483" } } }, { "@type": "MedicalWebPage", "name": "Histone deacetylases", "alternateName": "Histone Deacetylases", "url": "https://questionsmedicales.fr/mesh/D006655", "about": { "@type": "MedicalCondition", "name": "Histone deacetylases", "code": { "@type": "MedicalCode", "code": "D006655", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Group III Histone Deacetylases", "alternateName": "Group III Histone Deacetylases", "url": "https://questionsmedicales.fr/mesh/D056545", "about": { "@type": "MedicalCondition", "name": "Group III Histone Deacetylases", "code": { "@type": "MedicalCode", "code": "D056545", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520.200" } } }, { "@type": "MedicalWebPage", "name": "Histone deacetylase 6", "alternateName": "Histone Deacetylase 6", "url": "https://questionsmedicales.fr/mesh/D000073864", "about": { "@type": "MedicalCondition", "name": "Histone deacetylase 6", "code": { "@type": "MedicalCode", "code": "D000073864", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520.350" } } } ] }, { "@type": "MedicalWebPage", "name": "Nicotinamidase", "alternateName": "Nicotinamidase", "url": "https://questionsmedicales.fr/mesh/D009535", "about": { "@type": "MedicalCondition", "name": "Nicotinamidase", "code": { "@type": "MedicalCode", "code": "D009535", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.610" } } }, { "@type": "MedicalWebPage", "name": "Penicillin amidase", "alternateName": "Penicillin Amidase", "url": "https://questionsmedicales.fr/mesh/D010399", "about": { "@type": "MedicalCondition", "name": "Penicillin amidase", "code": { "@type": "MedicalCode", "code": "D010399", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.690" } } }, { "@type": "MedicalWebPage", "name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase", "alternateName": "Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase", "url": "https://questionsmedicales.fr/mesh/D043524", "about": { "@type": "MedicalCondition", "name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase", "code": { "@type": "MedicalCode", "code": "D043524", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.725" } } }, { "@type": "MedicalWebPage", "name": "5-Oxoprolinase(ATP-hydrolysing)", "alternateName": "Pyroglutamate Hydrolase", "url": "https://questionsmedicales.fr/mesh/D011752", "about": { "@type": "MedicalCondition", "name": "5-Oxoprolinase(ATP-hydrolysing)", "code": { "@type": "MedicalCode", "code": "D011752", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.760" } } }, { "@type": "MedicalWebPage", "name": "Urease", "alternateName": "Urease", "url": "https://questionsmedicales.fr/mesh/D014510", "about": { "@type": "MedicalCondition", "name": "Urease", "code": { "@type": "MedicalCode", "code": "D014510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.902" } } } ], "about": { "@type": "MedicalCondition", "name": "Amidohydrolases", "alternateName": "Amidohydrolases", "code": { "@type": "MedicalCode", "code": "D000581", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Rolandas Meškys", "url": "https://questionsmedicales.fr/author/Rolandas%20Me%C5%A1kys", "affiliation": { "@type": "Organization", "name": "Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania." } }, { "@type": "Person", "name": "Yumei Hu", "url": "https://questionsmedicales.fr/author/Yumei%20Hu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } }, { "@type": "Person", "name": "Longhai Dai", "url": "https://questionsmedicales.fr/author/Longhai%20Dai", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Sinofn (Tianjin) Pharmaceutical Technology Co., Ltd, Tianjin 300308, PR China." } }, { "@type": "Person", "name": "Du Niu", "url": "https://questionsmedicales.fr/author/Du%20Niu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } }, { "@type": "Person", "name": "Zhenzhen Xie", "url": "https://questionsmedicales.fr/author/Zhenzhen%20Xie", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Auditory central pathways in children and adolescents with multiple sclerosis.", "datePublished": "2023-10-18", "url": "https://questionsmedicales.fr/article/37852288", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/s-0043-1775985" } }, { "@type": "ScholarlyArticle", "name": "Neural tracking as a diagnostic tool to assess the auditory pathway.", "datePublished": "2022-09-14", "url": "https://questionsmedicales.fr/article/36137861", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.heares.2022.108607" } }, { "@type": "ScholarlyArticle", "name": "Aging process and central auditory pathway: a study based on auditory brainstem evoked potential and frequency-following response.", "datePublished": "2022-05-27", "url": "https://questionsmedicales.fr/article/35649058", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.31744/einstein_journal/2022AO6829" } }, { "@type": "ScholarlyArticle", "name": "Study of auditory pathways in type 1 diabetes mellitus through brainstem auditory evoked potentials and contralateral acoustic reflex.", "datePublished": "2023-05-08", "url": "https://questionsmedicales.fr/article/37194912", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/2317-1782/20232021022" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of auditory pathway by EABR before cochlear implantation and the postoperative effect analysis.", "datePublished": "2022-05-31", "url": "https://questionsmedicales.fr/article/35639140", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00405-022-07458-9" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Hydrolases", "item": "https://questionsmedicales.fr/mesh/D006867" }, { "@type": "ListItem", "position": 5, "name": "Amidohydrolases", "item": "https://questionsmedicales.fr/mesh/D000581" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Amidohydrolases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Amidohydrolases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Amidohydrolases", "description": "Comment diagnostiquer une déficience en amidohydrolases ?\nQuels tests sanguins sont utilisés pour évaluer les amidohydrolases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème d'amidohydrolases ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Auditory+Pathways#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Amidohydrolases", "description": "Quels sont les symptômes d'une déficience en amidohydrolases ?\nLes troubles métaboliques sont-ils liés aux amidohydrolases ?\nY a-t-il des signes cutanés associés aux troubles enzymatiques ?\nLes symptômes varient-ils selon le type d'amidohydrolase ?\nLes symptômes sont-ils immédiats ou progressifs ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Auditory+Pathways#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Amidohydrolases", "description": "Peut-on prévenir les troubles liés aux amidohydrolases ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nUne alimentation équilibrée peut-elle prévenir ces troubles ?\nLes vaccinations ont-elles un rôle dans la prévention ?\nL'éducation sur les maladies héréditaires est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Auditory+Pathways#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Amidohydrolases", "description": "Quels traitements existent pour les déficiences en amidohydrolases ?\nLes médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?\nLa thérapie génique est-elle une option pour ces troubles ?\nLes changements alimentaires peuvent-ils améliorer les symptômes ?\nY a-t-il des traitements naturels pour les troubles d'amidohydrolases ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Auditory+Pathways#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Amidohydrolases", "description": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?\nLes troubles d'amidohydrolases peuvent-ils affecter la croissance ?\nY a-t-il des risques de maladies auto-immunes ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Auditory+Pathways#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Amidohydrolases", "description": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?\nL'âge influence-t-il le risque de troubles enzymatiques ?\nLes maladies métaboliques augmentent-elles le risque ?\nLe mode de vie peut-il influencer le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Auditory+Pathways#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en amidohydrolases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses génétiques peuvent être effectués." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés pour évaluer les amidohydrolases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les dosages enzymatiques dans le sérum peuvent indiquer l'activité des amidohydrolases." } }, { "@type": "Question", "name": "Les biopsies sont-elles nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, des biopsies peuvent être nécessaires pour évaluer l'activité enzymatique." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème d'amidohydrolases ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles digestifs ou métaboliques peuvent signaler une anomalie enzymatique." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications associées." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en amidohydrolases ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs abdominales, des ballonnements et des troubles digestifs." } }, { "@type": "Question", "name": "Les troubles métaboliques sont-ils liés aux amidohydrolases ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une activité enzymatique anormale peut entraîner divers troubles métaboliques." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés aux troubles enzymatiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées peuvent survenir en raison de déséquilibres métaboliques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type d'amidohydrolase ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'enzyme spécifique impliquée." } }, { "@type": "Question", "name": "Les symptômes sont-ils immédiats ou progressifs ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être progressifs, se développant avec le temps en fonction de la déficience." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés aux amidohydrolases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Les tests génétiques peuvent-ils aider à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les personnes à risque de déficiences enzymatiques." } }, { "@type": "Question", "name": "Une alimentation équilibrée peut-elle prévenir ces troubles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé enzymatique, mais ne garantit pas la prévention." } }, { "@type": "Question", "name": "Les vaccinations ont-elles un rôle dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne sont pas directement liées à la prévention des troubles enzymatiques." } }, { "@type": "Question", "name": "L'éducation sur les maladies héréditaires est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation peut aider les familles à comprendre et à gérer les risques associés." } }, { "@type": "Question", "name": "Quels traitements existent pour les déficiences en amidohydrolases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent moduler l'activité enzymatique, mais leur efficacité varie." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour ces troubles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles." } }, { "@type": "Question", "name": "Les changements alimentaires peuvent-ils améliorer les symptômes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation adaptée peut aider à gérer les symptômes liés aux déficiences enzymatiques." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour les troubles d'amidohydrolases ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines approches naturelles peuvent aider, mais il est essentiel de consulter un médecin." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications digestives, métaboliques et neurologiques peuvent se développer." } }, { "@type": "Question", "name": "Les troubles d'amidohydrolases peuvent-ils affecter la croissance ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déficiences enzymatiques peuvent entraîner des retards de croissance chez les enfants." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies auto-immunes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre les troubles enzymatiques et les maladies auto-immunes." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications potentielles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis réguliers avec des professionnels de santé sont essentiels pour surveiller les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies génétiques et des régimes alimentaires déséquilibrés." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de troubles enzymatiques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles enzymatiques se manifestent plus fréquemment à des âges spécifiques." } }, { "@type": "Question", "name": "Les maladies métaboliques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies métaboliques peuvent prédisposer à des déficiences en amidohydrolases." } }, { "@type": "Question", "name": "Le mode de vie peut-il influencer le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie malsain, incluant une mauvaise alimentation, peut augmenter le risque." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes liés aux amidohydrolases." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 16/03/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

23 au total
└─

N-acetylmuramoyl-l-alanine amidase

N-Acetylmuramoyl-L-alanine Amidase D009238 - D08.811.277.087.030
└─

Allophanate hydrolase

Allophanate Hydrolase D000492 - D08.811.277.087.060
└─

Formamidase

Arylformamidase D005558 - D08.811.277.087.100
└─

Asparaginase

Asparaginase D001215 - D08.811.277.087.116
└─

N4-(beta-N-acetylglucosaminyl)-L-asparaginase

Aspartylglucosylaminase D001227 - D08.811.277.087.125
└─

bêta-Lactamases

beta-Lactamases D001618 - D08.811.277.087.180
└─

Biotinidase

Biotinidase D043523 - D08.811.277.087.200
└─

Ceramidases

Ceramidases D055572 - D08.811.277.087.250
└─

Dihydro-orotase

Dihydroorotase D004080 - D08.811.277.087.280
└─

Glutaminase

Glutaminase D005972 - D08.811.277.087.483
└─

Histone deacetylases

Histone Deacetylases D006655 - D08.811.277.087.520
└─

Nicotinamidase

Nicotinamidase D009535 - D08.811.277.087.610
└─

Penicillin amidase

Penicillin Amidase D010399 - D08.811.277.087.690
└─

Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase

Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase D043524 - D08.811.277.087.725
└─

5-Oxoprolinase(ATP-hydrolysing)

Pyroglutamate Hydrolase D011752 - D08.811.277.087.760
└─

Urease

Urease D014510 - D08.811.277.087.902
└─└─

Cephalosporinase

Cephalosporinase D002510 - D08.811.277.087.180.229
└─└─

Penicillinase

Penicillinase D010405 - D08.811.277.087.180.697
└─└─

Acid Ceramidase

Acid Ceramidase D055573 - D08.811.277.087.250.100
└─└─

Alkaline Ceramidase

Alkaline Ceramidase D055574 - D08.811.277.087.250.300
└─└─

Neutral Ceramidase

Neutral Ceramidase D055576 - D08.811.277.087.250.650
└─└─

Group III Histone Deacetylases

Group III Histone Deacetylases D056545 - D08.811.277.087.520.200
└─└─

Histone deacetylase 6

Histone Deacetylase 6 D000073864 - D08.811.277.087.520.350

Auteurs principaux

Rolandas Meškys

3 publications dans cette catégorie

Affiliations :
  • Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.

Yumei Hu

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Longhai Dai

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Sinofn (Tianjin) Pharmaceutical Technology Co., Ltd, Tianjin 300308, PR China.
Publications dans "Amidohydrolases" :

Du Niu

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Zhenzhen Xie

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Panpan Shen

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Xian Li

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Hao Li

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Jian Min

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Rey-Ting Guo

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Zhejiang Key Laboratory of Medical Epigenetics, Department of Immunology and Pathogen Biology, School of Basic Medical Sciences, Hangzhou Normal University, 311121 Hangzhou, PR China.
Publications dans "Amidohydrolases" :

Chun-Chi Chen

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Zhejiang Key Laboratory of Medical Epigenetics, Department of Immunology and Pathogen Biology, School of Basic Medical Sciences, Hangzhou Normal University, 311121 Hangzhou, PR China. Electronic address: ccckate0722@hubu.edu.cn.
Publications dans "Amidohydrolases" :

Agota Aučynaitė

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Joanna I Loch

2 publications dans cette catégorie

Affiliations :
  • Department of Crystal Chemistry and Crystal Physics, Faculty of Chemistry, Jagiellonian University, Krakow, Poland.

Mariusz Jaskolski

2 publications dans cette catégorie

Affiliations :
  • Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
  • Department of Crystallography, Faculty of Chemistry, Adam Mickiewicz University, Poznan, Poland.

Roberta Statkevičiūtė

1 publication dans cette catégorie

Affiliations :
  • Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.
Publications dans "Amidohydrolases" :

Mikas Sadauskas

1 publication dans cette catégorie

Affiliations :
  • Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.
Publications dans "Amidohydrolases" :

Juta Rainytė

1 publication dans cette catégorie

Affiliations :
  • Department of Eukaryote Gene Engineering, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.
Publications dans "Amidohydrolases" :

Karolina Kavaliauskaitė

1 publication dans cette catégorie

Affiliations :
  • Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.
Publications dans "Amidohydrolases" :

Markus R Busch

1 publication dans cette catégorie

Affiliations :
  • Institute of Biophysics and Physical Biochemistry, Regensburg Center for Biochemistry, University of Regensburg, D-93040 Regensburg, Germany.
Publications dans "Amidohydrolases" :

Chitra Rajendran

1 publication dans cette catégorie

Affiliations :
  • Institute of Biophysics and Physical Biochemistry, Regensburg Center for Biochemistry, University of Regensburg, D-93040 Regensburg, Germany.
Publications dans "Amidohydrolases" :

Sources (10000 au total)

Auditory central pathways in children and adolescents with multiple sclerosis.

Multiple sclerosis (MS) is an inflammatory demyelinating disease. Auditory evoked potential studies have demonstrated conduction and neural processing deficits in adults with MS, but little is known a... to evaluate the central auditory pathway with brainstem auditory evoked potentials (BAEP) and long-latency auditory evoked potentials (LLAEP) in children and adolescents with MS.... The study comprised 17 individuals with MS, of both sexes, aged 9 to 18 years, and 17 healthy volunteers, matched for age and sex. All individuals had normal hearing and no middle ear impairments. The... Abnormal responses were observed in 60% of electrophysiologic assessments of individuals with MS. In BAEP, 58.82% of MS patients had abnormal responses, with longer wave V latency and therefore longer... Children and adolescents with MS had abnormal BAEP responses, with delayed neural conduction between the cochlear nucleus and the lateral lemniscus. Also, abnormal LLAEP results suggest a decrease in ...

Aging process and central auditory pathway: a study based on auditory brainstem evoked potential and frequency-following response.

To analyze age-related changes in the central auditory pathway in healthy elderly individuals.... A prospective, quantitative cross-sectional study. The caseload comprised 18 adults (mean age, 22.78 years) and 18 elderly individuals (mean age, 66.72 years) of both sexes, who met inclusion criteria... Elderly individuals had higher wave and interpeak latencies (waves I, III and V and interpeaks I-V and III-V) of brainstem auditory evoked potential. Latencies of frequency following response waves A,... Brainstem auditory evoked potential and frequency-following response allowed appropriate assessment of age-related changes in the auditory pathway. Slower neural response to auditory stimuli suggests ...

Study of auditory pathways in type 1 diabetes mellitus through brainstem auditory evoked potentials and contralateral acoustic reflex.

To investigate the functionalities of the neural pathways through the auditory evoked potentials of the brainstem and the contralateral stapedial acoustic reflexes in normal-hearing individuals with t... This is a cross-sectional study with a comparison group and a convenience sample, consisting of 32 individuals with type 1 diabetes mellitus and 20 controls without the disease. All subjects had heari... The auditory thresholds of the acoustic reflex were statistically lower in the group with the disease at frequencies of 0.5 kHz and 1.0 kHz in the left ear (p=0.01 and p=0.01, respectively). The absol... The findings suggest that subjects with type 1 diabetes mellitus are more likely to present alterations in the central auditory pathways, even with auditory thresholds within normal limits....

Evaluation of auditory pathway by EABR before cochlear implantation and the postoperative effect analysis.

To investigate the evaluation value of electrically evoked auditory brainstem response (EABR) monitoring before cochlear implantation in patients with cochlear nerve defects (CND).... A total of 54 patients with cochlear nerve defects who underwent cochlear implantation in our hospital from 2011 to 2018 were selected as the CND group, and 20 patients with normal cochlear implantati... The EABR waveform of the CND group was significantly different from the control group in terms of average wave V threshold, average dynamic range and V-wave I/O curve slope (P < 0.05). Average C value... The EABR test can be used to evaluate the auditory pathway function before cochlear implantation and its postoperative effect in patients with CND....

A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia.

To characterize the peripheral and central auditory pathways in individuals with Acute Lymphoid Leukemia (ALL) and compare assessment results before and during chemotherapy.... The study included 17 subjects with ALL, divided into two age groups: 3 to 6 (11 individuals) and 7 to 16 years old (6 individuals). Each subject was evaluated twice (before and 3 to 6 months after ch... PTA was normal. Tympanometry was abnormal in the second assessment in 2 individuals aged 3 to 6 years. One subject in each age group had absent ipsilateral acoustic reflexes. In high-frequency audiome... No hearing loss was identified in the behavioral audiological assessment. BAEP was more affected in the 3-to-6-year-old group, with greater impairment in the lower brainstem in the first and second as...

Evaluation of auditory pathway excitability using a pre-operative trans-tympanic electrically evoked auditory brainstem response under local anesthesia in cochlear implant candidates.

Subjective promontory stimulation is used to evaluate cochlear implant (CI) candidacy, but the test reliability is low. Electrically evoked auditory brainstem response (EABR) can verify the function o... We hypothesised that LA-TT-EABR waveforms of good quality would be related to successful hearing outcomes. We assumed that the duration of hearing loss/deafness was a confounding factor to study outco... 19 borderline CI candidates.... Positive LA-TT-EABR results were confirmed in 14 patients. LA-TT-EABR's mean latency was 2.05 ± 0.31 ms (eII/eIII) and 4.24 ± 0.39 ms (eIV/eV). Latencies weren't statistically different from intra-ope... LA-TT-EABR is a tool in the frame of pre-operative objective testing the auditory pathway. It seems useful for clinical testing CI candidacy. Based on this study's outcomes, LA-TT-EABR should be recom...